215 related articles for article (PubMed ID: 26598674)
1. Multifaceted contribution of the TLR4-activated IRF5 transcription factor in systemic sclerosis.
Saigusa R; Asano Y; Taniguchi T; Yamashita T; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Sugawara K; Tsuruta D; Taniguchi T; Sato S
Proc Natl Acad Sci U S A; 2015 Dec; 112(49):15136-41. PubMed ID: 26598674
[TBL] [Abstract][Full Text] [Related]
2. Amelioration of tissue fibrosis by toll-like receptor 4 knockout in murine models of systemic sclerosis.
Takahashi T; Asano Y; Ichimura Y; Toyama T; Taniguchi T; Noda S; Akamata K; Tada Y; Sugaya M; Kadono T; Sato S
Arthritis Rheumatol; 2015 Jan; 67(1):254-65. PubMed ID: 25302613
[TBL] [Abstract][Full Text] [Related]
3. Glycyrrhizin Ameliorates Fibrosis, Vasculopathy, and Inflammation in Animal Models of Systemic Sclerosis.
Yamashita T; Asano Y; Taniguchi T; Nakamura K; Saigusa R; Miura S; Toyama T; Takahashi T; Ichimura Y; Yoshizaki A; Trojanowska M; Sato S
J Invest Dermatol; 2017 Mar; 137(3):631-640. PubMed ID: 27777101
[TBL] [Abstract][Full Text] [Related]
4. Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient mice.
Taniguchi T; Asano Y; Akamata K; Noda S; Takahashi T; Ichimura Y; Toyama T; Trojanowska M; Sato S
Arthritis Rheumatol; 2015 Feb; 67(2):517-26. PubMed ID: 25385187
[TBL] [Abstract][Full Text] [Related]
5. Phenotype-haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severity.
Dieude P; Dawidowicz K; Guedj M; Legrain Y; Wipff J; Hachulla E; Diot E; Sibilia J; Mouthon L; Cabane J; Amoura Z; Crakowski JL; Carpentier P; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
J Rheumatol; 2010 May; 37(5):987-92. PubMed ID: 20231204
[TBL] [Abstract][Full Text] [Related]
6. Promotion of Inflammatory Arthritis by Interferon Regulatory Factor 5 in a Mouse Model.
Duffau P; Menn-Josephy H; Cuda CM; Dominguez S; Aprahamian TR; Watkins AA; Yasuda K; Monach P; Lafyatis R; Rice LM; Kenneth Haines G; Gravallese EM; Baum R; Richez C; Perlman H; Bonegio RG; Rifkin IR
Arthritis Rheumatol; 2015 Dec; 67(12):3146-57. PubMed ID: 26315890
[TBL] [Abstract][Full Text] [Related]
7. STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis.
Dieudé P; Guedj M; Wipff J; Ruiz B; Hachulla E; Diot E; Granel B; Sibilia J; Tiev K; Mouthon L; Cracowski JL; Carpentier PH; Amoura Z; Fajardy I; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
Arthritis Rheum; 2009 Aug; 60(8):2472-9. PubMed ID: 19644887
[TBL] [Abstract][Full Text] [Related]
8. Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population.
Ito I; Kawaguchi Y; Kawasaki A; Hasegawa M; Ohashi J; Hikami K; Kawamoto M; Fujimoto M; Takehara K; Sato S; Hara M; Tsuchiya N
Arthritis Rheum; 2009 Jun; 60(6):1845-50. PubMed ID: 19479858
[TBL] [Abstract][Full Text] [Related]
9. Association of the IRF5 SNP rs2004640 with systemic sclerosis in Han Chinese.
Wang J; Yi L; Guo X; Liu M; Li H; Zou H; Gu Y; Tu W; Guo G; Yang L; Lai S; He D; Zhou X
Int J Immunopathol Pharmacol; 2014; 27(4):635-8. PubMed ID: 25572744
[TBL] [Abstract][Full Text] [Related]
10. TLR4-dependent fibroblast activation drives persistent organ fibrosis in skin and lung.
Bhattacharyya S; Wang W; Qin W; Cheng K; Coulup S; Chavez S; Jiang S; Raparia K; De Almeida LMV; Stehlik C; Tamaki Z; Yin H; Varga J
JCI Insight; 2018 Jul; 3(13):. PubMed ID: 29997297
[TBL] [Abstract][Full Text] [Related]
11. Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis.
Dieudé P; Guedj M; Wipff J; Avouac J; Fajardy I; Diot E; Granel B; Sibilia J; Cabane J; Mouthon L; Cracowski JL; Carpentier PH; Hachulla E; Meyer O; Kahan A; Boileau C; Allanore Y
Arthritis Rheum; 2009 Jan; 60(1):225-33. PubMed ID: 19116937
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological Inhibition of Toll-Like Receptor-4 Signaling by TAK242 Prevents and Induces Regression of Experimental Organ Fibrosis.
Bhattacharyya S; Wang W; Tamaki Z; Shi B; Yeldandi A; Tsukimi Y; Yamasaki M; Varga J
Front Immunol; 2018; 9():2434. PubMed ID: 30405628
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in STAT4 and IRF5 increase the risk of systemic sclerosis: a meta-analysis.
Xu Y; Wang W; Tian Y; Liu J; Yang R
Int J Dermatol; 2016 Apr; 55(4):408-16. PubMed ID: 26712637
[TBL] [Abstract][Full Text] [Related]
14. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice.
Tada Y; Kondo S; Aoki S; Koarada S; Inoue H; Suematsu R; Ohta A; Mak TW; Nagasawa K
Arthritis Rheum; 2011 Mar; 63(3):738-48. PubMed ID: 21305501
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in animal models of systemic sclerosis.
Asano Y
J Dermatol; 2016 Jan; 43(1):19-28. PubMed ID: 26782003
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic suppression of Fli1, a potential predisposing factor in the pathogenesis of systemic sclerosis.
Asano Y
Int J Biochem Cell Biol; 2015 Oct; 67():86-91. PubMed ID: 26055516
[TBL] [Abstract][Full Text] [Related]
17. The status of pulmonary fibrosis in systemic sclerosis is associated with IRF5, STAT4, IRAK1, and CTGF polymorphisms.
Zhao W; Yue X; Liu K; Zheng J; Huang R; Zou J; Riemekasten G; Petersen F; Yu X
Rheumatol Int; 2017 Aug; 37(8):1303-1310. PubMed ID: 28434122
[TBL] [Abstract][Full Text] [Related]
18. Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus.
Savitsky DA; Yanai H; Tamura T; Taniguchi T; Honda K
Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10154-9. PubMed ID: 20479222
[TBL] [Abstract][Full Text] [Related]
19. CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma.
Yoshizaki A; Iwata Y; Komura K; Ogawa F; Hara T; Muroi E; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Tedder TF; Sato S
Am J Pathol; 2008 Jun; 172(6):1650-63. PubMed ID: 18467694
[TBL] [Abstract][Full Text] [Related]
20. 4F decreases IRF5 expression and activation in hearts of tight skin mice.
Xu H; Krolikowski JG; Jones DW; Ge ZD; Pagel PS; Pritchard KA; Weihrauch D
PLoS One; 2012; 7(12):e52046. PubMed ID: 23251680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
